Abstract:Objective To screen potential serum HCC associated proteins with low molecular weight and low abundance for better understanding the pathological mechanism of HCC and discovering new biomarkers.Methods All serum samples were collected from 81 HBV-related HCC patients,43 chronic hepatitis B patients and 36 cirrhosis patients.Serum protein fingerprint profiles were first generated by selected WCX2 protein chip integrating with SELDI-TOF-MS,and then normalized and aligned by Ciphergen SELDI Software 3.1.1 with Biomarker Wizard.Comparative analysis of the intensity of corresponding protein fingerprint peaks in normalized protein spectra was performed.Some protein peaks with significant difference among HCC,cirrhosis and chronic hepatitis B groups were found.The reproducibility of the SELDI system was assessed before serum protein fingerprint profiles analysis.Results The intra-and inter-assay CV for intensity and m/z in this SELDI system were 17.46% and 0.024%,and 17.74% and 0.024% respectively.Total 128 protein fingerprint peaks between 2 000 to 30 000 Da were identified under the condition of signal to noise＞5 and minimum threshold for cluster＞20%.Eighty-seven proteins were found to significantly expressed between HCC and cirrhosis groups(P＜0.05).Of the above differential proteins,forty-five proteins had changes greater than two fold,including 15 up-regulated proteins and 30 downregulated proteins in HCC sera.Between HCC and chronic hepatitis B groups,nine of fifty-two differential proteins(P＜0.05) had intensities of more than two folds,including 2 up-regulated proteins and 7 downregulated proteins in HCC sera.Between cirrhosis and chronic hepatitis B groups,twenty-eight of seventynine significantly differential proteins(P＜0.05) changed greater than two folds in intensity,including 17 up-regulated proteins in cirrhosis seru and 11 down-regulated proteins in chronic hepatitis B sera.Analysis of above leading differential proteins among three diseases using subtraction difference mode,the 5 common down-regulated proteins 2 870,3 941,2 688,3 165 and 5 483 m/z in HCC sera and 2 common up-regulated proteins 3 588 and 2 017 m/z in cirrhosis and HCC sera were screened.But no statistic difference in the level of protein 2 017m/z was found between HCC group and normal group inour previous study.Conclusion Because the interference of unspecific proteins from hepatitis B and cirrhosis could be eliminated partly in HCC sera through subtraction difference analysis,these 6 common differential proteins (2 870,3 941,2 688,3 165,5 483,3 588 m/z)have obvious advantages of increased specificity for evaluating the pathological state of HCC and might become promising candidate biomarkers in the diagnosis of HCC.\r\n\r\nKey words: \r\nLiver neoplasms; Carcinoma,hepatocellular; Spectrometry,mass,matrix-assisted laser desorption ionization; Protein array analysis; Biological marker

Profiling serum low molecular weight proteins in patients with chronic severe hepatitis

Screening Serum Hepatocellular Carcinoma-Associated Proteins by SELDI-based Protein Spectrum Analysis

HCC serum associated proteins screened by SELDI-TOF-MS analysis

An approach to the characterization of serum low-molecular weight proteins/peptides in liver injury using SELDI-TOF MS and factor analysis.

The primary research on different expressing of plasma proteomics in chronic severe hepatitis B

Surface Enhanced Laser Desorption/Ionization Profiling: New Diagnostic Method of Hbv-Related Hepatocellular Carcinoma

Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate.

Combination of Multi Chips and Multi Data Analysis Methods in a Primary Analysis of Plasma Proteome in Liver Fibrosis Patients

Serum lipidomic analysis of patients with chronic hepatitis B

Detection of serum markers by SELDI-TOF-MS protein chip technology in non-active hepatitis B s' antigen carriers

Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B

Purification and identification of serum protein biomarkers with relation to portal vein tumor thrombi screened by SELDI-TOF MS

Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study

Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.

Serum Proteomics Analysis and Comparisons Using Itraq in the Progression of Hepatitis B

Serum Proteomic MRM Identify Peptide Ions of Transferrin As New Fibrosis Markers in Chronic Hepatitis B.

Mass spectrometric analysis of peripheral blood mononuclear cells in patients with hepatitis B virus associated hepatocellular carcinoma or liver cirrhosis

Serum MRM assay for stage-related protein biomarkers on HBV infected liver fibrosis patients

Comparison of the Serum Proteome Fingerprint Between Biliary Atresia and Cholestatic Hepatitis in Children

Clinical Significance of Biomarkers from Serum in Liver Cancer by SELDI-TOF Mass Spectrometry

Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.